Bowel cancer “melted away” after immunotherapy, then stayed away
出典: Science Daily元のソースで開く ↗
10/10/2026 às 18:421 閲覧
📷 Imagem protegida por direitos autorais de Science Daily. Veja na 原文を開く ↗
A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab for up to nine weeks before surgery instead of…
全文はこちら
Science Daily
⚖️ 出典と原文へのリンクを示したうえで、抜粋のみを引用しています（引用権：アイスランド著作権法第73/1972号第14条・ベルヌ条約第10条）。
このニュースは役立ちましたか？
議論 0
Seja o primeiro a contribuir com o debate.